Breast Cancer News and Research

Latest Breast Cancer News and Research

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.

23 Jan 2013

Synthon Biopharmaceuticals announces promising results with its antibody-drug conjugate program

Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).

22 Jan 2013

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

Honeybee silk-inspired materials; a deconstruction of the Ebola virus; how microbes evolve resistance to antibiotics; and a possible connection between Alzheimer's disease and type II diabetes are just some of the intriguing topics that will be presented at the 57th Annual Meeting of the Biophysical Society (BPS).

22 Jan 2013

BRCA1-deficient cancer cells take advantage of DNA repair mechanism

Cancer cells are resourceful survivors with plenty of tricks for staying alive. Researchers have uncovered one of these stratagems, showing how cells lacking the tumor suppressor BRCA1 can resume one form of DNA repair, sparing themselves from stagnation or death. The study appears in the January 21st issue of The Journal of Cell Biology.

22 Jan 2013

MRI ‘good accuracy’ for detecting residual breast cancer

Magnetic resonance imaging is superior to mammography for the detection of residual breast cancer after neoadjuvant chemotherapy, research confirms.

21 Jan 2013

New study: Loneliness can harm overall health

New research links loneliness to a number of dysfunctional immune responses, suggesting that being lonely has the potential to harm overall health.

20 Jan 2013

Researchers analyse breast cancer mortality in Spain among different age groups from 1981-2007

Since 1992 the number of deaths linked to breast cancer in Spain has decreased among young and middle aged patients but not among the elderly. Spanish researchers also predict that it will continue to decline over the next decade, although more slowly as observed up until now.

18 Jan 2013

Medications often prescribed for PAH could affect heart health of treated patients

A research team with the Faculty of Medicine & Dentistry at the University of Alberta reported findings that significantly improve understanding of how widely used drugs in Pulmonary Arterial Hypertension (PAH) affect the heart health of treated patients.

18 Jan 2013

Report: Cancer death rates decline 20% from its peak in 1991

As of 2009, the overall death rate for cancer in the United States had declined 20 percent from its peak in 1991, translating to the avoidance of approximately 1.2 million deaths from cancer, 152,900 of these in 2009 alone. These figures come from the American Cancer Society's annual Cancer Statistics report, one of the most widely-cited medical publications in the world.

17 Jan 2013

SyNAPSe® Trial by BHR Pharma deemed to have no safety issues according to DSMB

BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.

17 Jan 2013

US breast reconstruction trends highlighted

The number of women undergoing breast reconstruction immediately after mastectomy has increased in recent years in the USA, with implant use being the most common approach, research shows.

17 Jan 2013

Study identifies subgroups of patients with distinct, persistent pain after breast cancer surgery

Some 25 percent of breast cancer surgery patients experience significant, persistent pain six months after the procedure, and new research published in The Journal of Pain showed that women with preoperative breast pain have the highest risk for extended post-surgical pain.

17 Jan 2013

SF3B1 gene mutations in uveal melanoma linked to favorable features

Melanomas that develop in the eye often are fatal. Now, scientists at Washington University School of Medicine in St. Louis report they have identified a mutated gene in melanoma tumors of the eye that appears to predict a good outcome.

17 Jan 2013

Boehringer Ingelheim receives FDA Priority Review for afatinib to treat EGFR mutation-positive NSCLC

Boehringer Ingelheim today announced that the New Drug Application (NDA) for its investigational oncology compound afatinib has been accepted for filing and granted Priority Review by the U.S. Food and Drug Administration (FDA).

17 Jan 2013

State roundup: Texas, Ga. companies forming ACOs

College student Emily Howell depended on her local Planned Parenthood clinic. Now, she and nearly 50,000 other Texas women will have to find a new place to get free breast cancer screenings, pap smears and birth control.

16 Jan 2013

Tamoxifen can counteract some pathologic features in mouse model of DMD

A new study has found that tamoxifen, a well-known breast cancer drug, can counteract some pathologic features in a mouse model of Duchenne muscular dystrophy (DMD). At present, no treatment is known to produce long-term improvement of the symptoms in boys with DMD, a debilitating muscular disorder that is characterized by progressive muscle wasting, respiratory and cardiac impairments, paralysis, and premature death.

16 Jan 2013

NEDD9 gene controls growth of progenitor cells that give rise to breast tumors

Breast cancer is the second leading cause of cancer deaths among women in the United States. Many of these deaths occur when there is an initial diagnosis of invasive or metastatic disease. A protein called NEDD9-which regulates cell migration, division and survival-has been linked to tumor invasion and metastasis in a variety of cancers.

16 Jan 2013

Fox Chase's OHCHD to fund community-based patient navigation services

Fox Chase Cancer Center's Office of Health Communications and Health Disparities (OHCHD) recently received a grant from the National Breast Cancer Foundation to fund community-based patient navigation services.

16 Jan 2013

Aggressive breast cancer’s metastasis molecular switch identified

Scientists at Weill Cornell Medical College have discovered the molecular switch that allows aggressive triple negative breast cancer cells to grow the amoeba-like protrusions they need to crawl away from a primary tumor and metastasize throughout the body. Their findings, published in Cancer Cell, suggest a novel approach for developing agents to treat cancer once it has spread.

15 Jan 2013

Research roundup: Effectiveness of mobile clinics; Can more alternative medicine coverage save money?

Approximately 2,000 mobile health clinics in the U.S. have 6.5 million patient visits annually. Researchers analyzed data from nearly 6,000 patients from 2010 to 2012 from one program, to examine the clinical impact and cost-effectiveness.

15 Jan 2013

Breast Cancer News and Research

Latest Breast Cancer News and Research

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Synthon Biopharmaceuticals announces promising results with its antibody-drug conjugate program

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

BRCA1-deficient cancer cells take advantage of DNA repair mechanism

MRI ‘good accuracy’ for detecting residual breast cancer

New study: Loneliness can harm overall health

Researchers analyse breast cancer mortality in Spain among different age groups from 1981-2007

Medications often prescribed for PAH could affect heart health of treated patients

Report: Cancer death rates decline 20% from its peak in 1991

SyNAPSe® Trial by BHR Pharma deemed to have no safety issues according to DSMB

US breast reconstruction trends highlighted

Study identifies subgroups of patients with distinct, persistent pain after breast cancer surgery

SF3B1 gene mutations in uveal melanoma linked to favorable features

Boehringer Ingelheim receives FDA Priority Review for afatinib to treat EGFR mutation-positive NSCLC

State roundup: Texas, Ga. companies forming ACOs

Tamoxifen can counteract some pathologic features in mouse model of DMD

NEDD9 gene controls growth of progenitor cells that give rise to breast tumors

Fox Chase's OHCHD to fund community-based patient navigation services

Aggressive breast cancer’s metastasis molecular switch identified

Research roundup: Effectiveness of mobile clinics; Can more alternative medicine coverage save money?

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in